Stockscreener 앱 받기
0.585
0.85%
-0.005
시간 외 거래:
.59
0.005
+0.85%
전일 마감가:
$0.59
열려 있는:
$0.586
하루 거래량:
7,330
Relative Volume:
0.00
시가총액:
$4.07M
수익:
-
순이익/손실:
$-736.70K
주가수익비율:
-58.50
EPS:
-0.01
순현금흐름:
$-4.14M
1주 성능:
+2.63%
1개월 성능:
-7.79%
6개월 성능:
-35.36%
1년 성능:
-55.00%
1일 변동 폭
$0.575
$0.6015
1주일 범위
$0.57
$0.615
52주 변동 폭
$0.51
$1.79
Xortx Therapeutics Inc Stock (XRTX) Company Profile
XRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.585 | 4.11M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스
Why XORTX Therapeutics Inc. stock remains resilientJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - ulpravda.ru
Is XORTX Therapeutics Inc. (ANUA) stock a buy before earnings resultsQuarterly Trade Review & Weekly Top Stock Performers List - ulpravda.ru
Will XORTX Therapeutics Inc. stock attract more institutional investorsPortfolio Risk Summary & Safe Investment Capital Preservation Plans - ulpravda.ru
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will XORTX Therapeutics Inc. stock beat EPS estimatesStock Split Announcements & High Profit Portfolio Growth - ulpravda.ru
Published on: 2026-01-07 21:30:14 - ulpravda.ru
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol - TipRanks
Huge gout genetics study highlights target in kidney disease research - Stock Titan
XORTX Announces USD $3 Million Offering - 富途牛牛
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update - Chartmill
Multi Factor Analysis Ranks Jaihind Synthetics Limited as Strong BuyInsider Selling Patterns & Lower Drawdowns With Smart Position Sizing - bollywoodhelpline.com
Order Book Volume Tilts Bullish on Adani Wilmar LimitedCurrency Fluctuation Impact & Breakout Stock Alerts - bollywoodhelpline.com
Chart Analysts Warn of Resistance Near Glance Finance Limited PriceCapital Gains Strategies & Small Capital Trading Plans - bollywoodhelpline.com
Fibonacci Levels Suggest Recovery for Johnson Pharmacare LimitedMomentum Trading Signals & Analysts Are Raving About These Shares - bollywoodhelpline.com
Global Longlife Hospital and Research Limited (543520) Sees Unusual Trading VolumeFinancial Sector Performance & Small Entry Cost Trading - bollywoodhelpline.com
Can Fabino Life Sciences Limited Bounce Back From Weekly LowEx-Dividend Date Alerts & Outstanding Investment Returns - bollywoodhelpline.com
What drives XORTX Therapeutics Inc stock priceEconomic Data Impact & Free Stock Market Mentorship Programs - earlytimes.in
Aug Decliners: Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Fast Gaining Stock Reports - ulpravda.ru
How XORTX Therapeutics Inc. stock reacts to inflationary pressures2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - Улправда
Why XORTX Therapeutics Inc. (ANUA) stock could be top winnerJuly 2025 Snapshot & Verified Entry Point Signals - Улправда
Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Pullbacks & Real-Time Market Sentiment Reports - Улправда
Is XORTX Therapeutics Inc. stock positioned well for digital economy2025 Price Targets & Scalable Portfolio Growth Methods - Улправда
Growth Value: Is XORTX Therapeutics Inc. stock positioned well for digital economyJuly 2025 Snapshot & Low Drawdown Trading Techniques - Улправда
Will XORTX Therapeutics Inc. stock attract ESG investorsCEO Change & Daily Technical Forecast Reports - Улправда
What technical charts say about XORTX Therapeutics Inc. stockStock Surge & Accurate Intraday Trading Signals - Улправда
Certain Stock Options of XORTX Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Aug Analyst Calls: Will XORTX Therapeutics Inc stock attract ESG investorsJuly 2025 Chart Watch & Growth Focused Stock Reports - BỘ NỘI VỤ
XORTX Therapeutics Announces US$1.1 Million Direct Offering - MSN
XORTX Therapeutics (XRTX) Stock Analysis Report | Financials & Insights - Benzinga
Can XORTX Therapeutics Inc. (ANUA) stock deliver strong annual returnsMarket Risk Analysis & Safe Entry Zone Tips - Newser
Is XORTX Therapeutics Inc. stock a defensive play in 2025Weekly Earnings Recap & Stepwise Swing Trade Plans - Newser
Is XORTX Therapeutics Inc. (ANUA) stock a buy for dividend portfoliosEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Why XORTX Therapeutics Inc. (ANUA) stock could outperform next yearJuly 2025 Outlook & Daily Volume Surge Signals - Newser
Why XORTX Therapeutics Inc. stock could see breakout soonJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Will XORTX Therapeutics Inc. stock deliver strong dividend growthWeekly Stock Report & High Accuracy Swing Trade Signals - Newser
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollar2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Can XORTX Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Is XORTX Therapeutics Inc. (ANUA) stock a buy before new product rolloutJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Xortx Therapeutics Inc (XRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
자본화:
|
볼륨(24시간):